Copyright ©The Author(s) 2019.
World J Gastroenterol. Apr 21, 2019; 25(15): 1797-1816
Published online Apr 21, 2019. doi: 10.3748/wjg.v25.i15.1797
Figure 2
Figure 2 Schematic overview of the mevalonate pathway. The scheme illustrates the site of action of statins, metformin and bromodomain and extra-terminal domain inhibitors (see text for details). BET: Bromodomain and extra-terminal domain; AMPK: AMP-activated protein kinase; GG-PP: Geranylgeranyl pyrophosphate.